What Does it Cover?
In this brief presentation, we will provide you with an introduction to selecting proper antibodies for use in ELISA-based diagnostic tests. We will also present an overview of our antibody portfolio, and production capabilities and processes.
We will discuss key considerations for IVD manufacturers when selecting an antibody, including antibody design, performance in the desired application, freedom of use, and supplier reliability.
This information will be of interest to individuals involved in developing, manufacturing, and using ELISA based immunoassays.
What Will You Learn?
Who Should Attend?
Michael Moehlenbrock, Ph.D.
Immunoassay Sales Specialist
Michael Moehlenbrock Ph. D. is currently a business development manager and specialist in the area of diagnostic immunoassays for Merck. Prior to this role Michael has held several roles in product management including head of product management for Merck’s research antibody portfolio. Michael holds a Ph. D., and Bachelor’s degree in Chemistry from St. Louis University where his interdisciplinary research areas of focus included microfluidic analytical chemistry, enzymatic biosensors and biofuels cells, enzymology, metabolic substrate channeling, and materials chemistry.
Christina De Wit, Ph.D.
Cell Marque Corporation
R&D Manager, Tissue Diagnostics
Christina is a Senior R&D Manager at Cell Marque Corporation, part of Merck Applied Solutions division. She has more than two decades of experience in the U.S. biotechnology sector (pharma, clinical diagnostics, and industrial enzymes). Her responsibilities include providing R&D expertise and guidance in Design and Development for IVD Clinical diagnostics as well as leading Innovation projects for Diagnostics Solutions.
Christina has a degree in Molecular Biology from U.C. Berkeley, completing her Honors thesis with 2013 Nobel Prize winner Dr. Randy Schekman. She recently received a Masters in Business Administration degree from Sacramento State.
Matthew Coussens, Ph.D.
Product Training Manager
Matt is currently the product training manager of diagnostics for Merck. His primary responsibility is driving technology and product education to Merck’s global customer base. Prior to this, he held a post-doctoral fellowship at Washington University in St Louis, MO, and earned a Ph.D. in Cell and Molecular Biology from the University of Hawaii at Manoa where his research focused on embryonic development and stem cell biology.